Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma
Authors:
Open Access
- 1 October 2014
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (10) , 1424-1429
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Pharmacological Characterization of Abediterol, a Novel Inhaled β2-Adrenoceptor Agonist with Long Duration of Action and a Favorable Safety Profile in Preclinical ModelsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Safety of long-acting β agonists for the treatment of asthma: clearing the airThorax, 2011